MNX buys Logical Freight Solutions to expand in Asia-Pacific
December 5, 2017
MNX Global Logistics has acquired Australian specialty healthcare logistics provider Logical Freight Solutions (LFS) to enhance its time- and temperature-sensitive logistics capabilities in Asia Pacific.
The acquisition will also let the Californian company serve the growing healthcare, life sciences and biotech market.
Founded in 1994 in Melbourne, Australia, LFS serves the healthcare industry, including life science, ag-bio, diagnostics, therapeutics, proteomics, medical devices, microbiology, genomics, chemicals, radio-pharmaceuticals, instruments, spare parts and all consumables for these industries.
"The pace of growth in patient-centric medicine, with its strict requirements for temperature-controlled transportation and time-definite delivery, underscores the role that specialty time-critical logistics providers will continue to play in the life sciences and healthcare industries," said MNX CEO Paul Martins. "LFS shares our customer-centric culture and geographic footprint. This combination allows our new and existing customers to experience an expanded suite of logistics services tailored specifically for the healthcare, life sciences and medical device industries around the world."
LFS has locations in Australia, New Zealand, Singapore, Hong Kong, Taiwan and the USA.
"Since its inception, Logical Freight Solutions has steadily built an infrastructure and specialised expertise that provides our customers with true door-to-door service, from internal supplier to end-user," said LFS CEO Steve Cheetham. "Joining MNX further propels the growth of our business and service offerings across new geographies, and gives our customers access to a diversified range of logistics services and new technologies."
This acquisition is part of a series of strategic moves to drive global growth and improve service to healthcare and life sciences customers. With expanded capabilities, MNX is positioned to support customers looking to grow throughout the entire Asia-Pacific region and the world.
MNX clients include companies in the biopharmaceutical, life sciences, medical device, aviation and entertainment industries.